Bank of New York Mellon Corp - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$6,235,000
+57.8%
260,902
-3.6%
0.00%0.0%
Q4 2020$3,952,000
+3.4%
270,673
+0.5%
0.00%0.0%
Q3 2020$3,823,000
-22.1%
269,247
-19.3%
0.00%0.0%
Q2 2020$4,908,000
+393.8%
333,622
+38.3%
0.00%
Q1 2020$994,000
-14.5%
241,259
-0.1%
0.00%
Q4 2019$1,162,000
-18.5%
241,483
+2.6%
0.00%
Q3 2019$1,425,000
-3.5%
235,326
+3.5%
0.00%
Q2 2019$1,477,000
-12.9%
227,443
-4.9%
0.00%
Q1 2019$1,696,000
+50.1%
239,173
+2.8%
0.00%
Q4 2018$1,130,000
-28.9%
232,611
+7.5%
0.00%
Q3 2018$1,590,000
+14.6%
216,332
-0.6%
0.00%
Q2 2018$1,388,000
+8.9%
217,575
-7.2%
0.00%
Q1 2018$1,275,000
+26.2%
234,349
-3.3%
0.00%
Q4 2017$1,010,000
-57.5%
242,344
-1.9%
0.00%
-100.0%
Q3 2017$2,379,000
-9.9%
246,960
+10.7%
0.00%0.0%
Q2 2017$2,641,000
+0.5%
223,163
+8.9%
0.00%0.0%
Q1 2017$2,627,000
+8.2%
204,928
+3.3%
0.00%0.0%
Q4 2016$2,429,000
+17.2%
198,446
+13.0%
0.00%0.0%
Q3 2016$2,073,000
+28.4%
175,631
-5.4%
0.00%
Q2 2016$1,614,000
+68.7%
185,657
+2.2%
0.00%
Q1 2016$957,000
-34.7%
181,658
-3.8%
0.00%
Q4 2015$1,465,000
+6.8%
188,796
+8.3%
0.00%
Q3 2015$1,372,000
-29.5%
174,381
-18.8%
0.00%
-100.0%
Q2 2015$1,945,000
-24.9%
214,664
+7.6%
0.00%0.0%
Q1 2015$2,590,000
-4.7%
199,526
-0.1%
0.00%0.0%
Q4 2014$2,717,000
+56.1%
199,632
+2.9%
0.00%
Q3 2014$1,740,000
-63.4%
193,939
-44.8%
0.00%
-100.0%
Q2 2014$4,752,000
+169.1%
351,268
+97.7%
0.00%
Q1 2014$1,766,000
-35.4%
177,647
-13.7%
0.00%
-100.0%
Q4 2013$2,735,000
-21.5%
205,773
-28.3%
0.00%0.0%
Q3 2013$3,486,000
+188.1%
287,138
+145.6%
0.00%
Q2 2013$1,210,000116,9330.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders